Table S2.
History and characteristics of the baboons
| Animal # | Age (years) |
Sex | Prior study history |
|---|---|---|---|
| Group 1 | |||
| Controls | |||
| 1 | 20 | M | No research history, breeder |
| 2 | 22 | F | No research history, breeder |
| CBA-GFP | |||
| 3 | 15 | F | No research history, breeder |
| 4 | 15 | M | No research history, breeder |
| VMD2-GFP | |||
| 5 | 22 | F | No research history, breeder |
| 6 | 22 | F | 1996: Vaccinated with hepatitis B vaccine 2000: C-section |
| 7 | 20 | F | 2000: C-section 2005: HIV vaccine study |
| 8 | 17 | F | No research history, breeder |
| Group 2 | |||
| RK-GFP | |||
| 9 | 6 | M | 2011: Xenotransplant study 2012: Ehrlichia study: attempted to infect with Erlichia using ticks 2013: Vaccinated with RSV vaccine to generate polyclonal antibodies |
| 10 | 6 | M | 2011: Xenotransplant study 2012: Erlichia study; attempted to infect with Ehrlichia using ticks 2013: Vaccinated with RSV vaccine to generate polyclonal antibodies |
| 11 | 6 | M | 2011: Xenotransplant study 2012: Erlichia study; attempted to infect with Ehrlichia using ticks 2013: Vaccinated with respiratory syncytial virus vaccine to generate polyclonal antibodies |
| 12 | 6 | M | 2011: Xenotransplant study 2012: Erlichia study; attempted to infect with Ehrlichia using ticks |
| 13 | 12 | M | 2005: On study for the therapeutic efficacy of compound used to increase fetal hemoglobin in red blood cells Breeder |
| 14 | 2 | M | No research history; has history of seizures |
| Controls | |||
| 15 | 7 | M | No research history; has history of seizures |
Note: The 15 baboons enrolled in this study are described, including previous research history.